Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory
- Status
- RECRUITING
- Phase
- PHASE1
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
- Status
- RECRUITING
- Phase
- N/A
MIF Involvement in AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
- Status
- COMPLETED
- Phase
- NA
Study to Assess Length of Remission With Intensive Chemotherapy in Rapidly Responding AML Patients.
- Status
- UNKNOWN
- Phase
- NA
Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3